Explore Your Topic

Latest News

Share Price / Index

February 15, 2019
Not intended for U.S. and UK Media

Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)

Read more
February 14, 2019
Not intended for U.S. and UK Media - American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019

Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer

Read more
January 8, 2019
New predictive seed placement technology delivers strong results in 2018:

Bayer expands digital innovation pipeline at The Climate Corporation to bring breakthrough digital tools to more farmers

Read more
News Overview

Advance Your Career

Explore Our Businesses

We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here.

Find Your Product

With our products we contribute to the health of people, animals and plants. Here you find an overview of the major Bayer products.

Last updated: February 5, 2019